Skip to content

Ncyte® NHP-C vCardiomyocytes

Discover Ncyte® NHP-C vCardiomyocytes, an advanced model for cardiovascular research, featuring a detailed user guide for optimal application in your studies.
TAKE THE FIRST STEP

Ncyte® NHP-C vCardiomyocytes are non-human primate cynomolgus iPSC-derived ventricular cardiomyocytes produced through a well-defined in vitro differentiation process. They express characteristic cardiac markers, including cardiac Troponin T and Alpha-Actinin, and provide researchers with a relevant model for MEA assays and immunocytochemistry applications. 

This protocol covers thawing, seeding, culturing, MEA plate preparation, and immunocytochemistry seeding of Ncyte® NHP-C vCardiomyocytes. Please read the entire user guide before using this product.




ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.

Download the user guide by filling out the form below: